Harry Iland

Essential thrombocythemia: an interim report from the Polycythemia Vera Study Group.

Seamus Murphy, Harry Iland, David S. H. Rosenthal et al. · PubMed · 1986 · 485 citations

Medicine, Hematology, Internal Medicine +9

All-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4)

Harry Iland, Ken Bradstock, Shane G. Supple et al. · Blood · 2012 · 340 citations · Full text

Medicine, Hematology, Oncology +15

Use of arsenic trioxide in remission induction and consolidation therapy for acute promyelocytic leukaemia in the Australasian Leukaemia and Lymphoma Group (ALLG) APML4 study: a non-randomised phase 2 trial

Harry Iland, Marnie Collins, Ken Bradstock et al. · The Lancet Haematology · 2015 · 170 citations

Medicine, Hematology, Oncology +10

Long-term survival in multiple myeloma is associated with a distinct immunological profile, which includes proliferative cytotoxic T-cell clones and a favourable Treg/Th17 balance

Christian Bryant, Hayley Suen, Ross Brown et al. · Blood Cancer Journal · 2013 · 135 citations · Full text

Life Sciences, Hematology, Immunology +17

The PRKAR1A gene is fused to RARA in a new variant acute promyelocytic leukemia

Alberto Catalano, Mark A. Dawson, Karthiga Somana et al. · Blood · 2007 · 132 citations · Full text

Life Sciences, Genetics, Molecular Genetics +9